Home GSK Announces EU Approval of Dostarlimab (Jemperli) in Combination with Chemotherapy for dMMR/MSI-H Advanced or Recurrent Endometrial Cancer

GSK Announces EU Approval of Dostarlimab (Jemperli) in Combination with Chemotherapy for dMMR/MSI-H Advanced or Recurrent Endometrial Cancer

Dec 11, 2023 16:01 CST Updated 16:01
GSK

Pharmaceutical R&D Manufacturer

European Union

The European Union (German: Europäische Union; French: Union européenne), abbreviated as the EU, is headquartered in Brussels, the capital of Belgium. It evolved from the European Communities and originally had six founding member states: Germany, France, Italy, the Netherlands, Belgium, and Luxembourg. The Union currently has 28 member states and 24 official languages.In December 1991, the European Council meeting in Maastricht adopted the Treaty on European Union, commonly known as the Maastricht Treaty. On November 1, 1993, the Maastricht Treaty officially entered into force, marking the formal establishment of the European Union. In 2012, the EU was awarded the Nobel Peace Prize.Donald Tusk serves as President of the European Council, and Antonio Tajani is President of the European Parliament. Jean-Claude Juncker, former Prime Minister of Luxembourg, is President of the European Commission.The EU’s treaties have been amended multiple times, and its operations are governed by the Treaty of Lisbon. Politically, all member states are democracies (according to The Economist’s 2008 Democracy Index). Economically, it constitutes the world’s second-largest economic entity (with Germany, France, and Italy being members of the G8). Militarily, the vast majority of EU member states are also members of the North Atlantic Treaty Organization (NATO).

GSK announced on December 11 that the European Commission has approved Dostarlimab (Jemperli) in combination with carboplatin and paclitaxel for the treatment of primary advanced or recurrent endometrial cancer with mismatch repair deficiency (dMMR) or high microsatellite instability (MSI-H).